Top Medical News

Plasma Tau Levels Serve as Biomarkers of Cognitive Decline in Lewy Body Dementia

January 17, 2022

By Abby Reinhard

Investigators measured p-tau181 and p-tau231 levels with in-house single molecule array assays and cognition with the Mini-Mental State Examination.

Cognitive and Behavioral Involvement in ALS May Be Distinct Phenotype

January 17, 2022

By Marco Meglio

Those who had crossovers of ALS and frontotemporal dementia had structural and functional resemblance to the patterns of damage of those with only behavioral variant frontotemporal dementia.

Using Tailored Cognitive Behavioral Therapy to Address Psychogenic Nonepileptic Seizures

January 17, 2022

By Matt Hoffman

Becky Tilahun, PhD, a clinical psychologist at Cleveland Clinic, offered insight into a recent study she and colleagues conducted exploring CBT-informed psychotherapy for patients with psychogenic nonepileptic seizures

This Week on NeurologyLive® — January 17, 2022

January 17, 2022

By NeurologyLive® Staff

Here's what is coming soon to NeurologyLive®.

Cerebral Amyloid Angiopathy-Associated Transient Focal Neurological Episodes May Increase Risk of ICH, Death

January 16, 2022

By Marco Meglio

The research also identified small subcortical cerebral amyloid angiopathy-associated acute ischemic stroke lesions as risk factors for death in these patients.

Featured

Episode 55: Treating Headache in the Emergency Department

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Anne-Maree Kelly, MD, MClinEd, FACEM.

NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders.

Disease Spotlight: NMOSD

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with neuromyelitis optica spectrum disorder, including interviews with experts in the field and the latest FDA actions.

Disease Spotlight: Multiple Sclerosis

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with multiple sclerosis, including interviews with experts in the field and the latest FDA actions.

Coverage of the 2021 American Epilepsy Society Annual Meeting

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

Latest Videos

Unmet Needs and the Future of Treatment for AD

Novel Oral Treatment Selection in RRMS

Reversing Neurodegeneration in Multiple Sclerosis

Higher Levels of Neurodegenerative Biomarkers in Hospitalized Patients With COVID-19: Jennifer Frontera, MD

Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD

MAO-B Inhibitors Underused in PD, CMS Proposes Decision on Aducanumab Coverage, PREMIUM II Trial of gammaCore Published

Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD

Disorders of Consciousness and COVID-19: David Fischer, MD

Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD

Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD

SAGE and BrainTest for Cognitive Assessment and Clinical Trial Enrollment: Douglas Scharre, MD

Clinical Experience as a Factor in the Inconsistencies of Migraine Care: Anne-Maree Kelly, MD

Development of SAGE for Early Dementia Detection: Douglas Scharre, MD

Most Recent

Evaluating Neurodegenerative Biomarkers in Hospitalized Patients With COVID-19, Alzheimer Disease

January 13, 2022

Article

Jennifer Frontera, MD, professor of neurology, NYU Langone Grossman School of Medicine, discussed findings from a recently published study investigating neurological complications in hospitalized patients with COVID-19.

Long-Term IV Edaravone Not Associated With Disease-Modifying Benefit in ALS

January 13, 2022

Article

Despite not providing additional, clinically relevant benefit for patients with amyotrophic lateral sclerosis as an add-on to standard therapy, the intravenous treatment was feasible and well tolerated.

Testing Methods for AD

January 13, 2022

Video

Dr Cummings relays how testing methods influence the treatment course for Alzheimer’s disease.

Spasticity, Dystonia Commonly Under-Identified in Children With High Cerebral Palsy Risk

January 13, 2022

Article

Only 30% of the observed cohort of more than 150 children had their hypertonia type specified as spasticity and/or dystonia by age 5 years, highlighting a need for additional education efforts.

FDA Action Update, December 2021: Approvals, Acceptances, Designations

January 13, 2022

Article

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

A Proven Option for Reversing Morning Akinesia for Patients With Parkinson Disease

January 13, 2022

Article

The results of a phase 4 study demonstrate the efficacy of APOKYN® (apomorphine hydrochloride injection) treatment.

ANAVEX 3-71 Meets Primary, Secondary End Points in Phase 1 Study

January 12, 2022

Article

The Anavex Life Sciences treatment was found to be well tolerated in all cohorts of healthy patients with no serious adverse events reported. It is in development for conditions such as frontotemporal dementia.

Comprehensive Care and Collaboration for Multiple Sclerosis

January 12, 2022

Article

Reflecting on 2021, Mitzi Joi Williams, MD, the founder and CEO of Joi Wellness Group MS Center discussed the positive repercussions of the COVID-19 pandemic, which allowed for more freedom when sharing data.

MAO-B Inhibitors May Be Underused for Parkinson Disease, Outperform COMT Inhibitors in Quality of Life

January 12, 2022

Article

Although both are dopamine reuptake inhibitors, those on MAO-B inhibitors demonstrated greater mean PDQ-39 mobility scores and EuroQol 5-dimension 3-level scores over a median of 4.5 years.

NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy

January 12, 2022

Article

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders.